Breaking News

Healthpoint Ltd to Pay $1 Mln to Massachusetts to Settle Marketing of Xenoderm Matter
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

On Friday, Massachusetts Attorney General Martha Coakley said Massachusetts had reached a settlement with Healthpoint and its general partner DFB Pharmaceuticals Inc as part of a broader national settlement of $48 million.

The settlement was to resolve allegations of wrongfully charging Medicaid and Medicare for the Xenaderm ointment though it was not approved by the FDA. According to Coakley, Massachusetts would be receiving $996,000. She said in a statement, “This settlement demonstrates the importance of policing the pharmaceutical industry and remaining vigilant with respect to drug marketing misconduct.”

However, the Texas-based Healthpoint has not admitted to any wrongdoing.


The national-level settlement had been announced by the DOJ in December last year, over the complaint it had filed under the False Claims Act in 2011. The complaint had filed against Healthpoint in the District of Masschusetts.

According to the complaint by the U.S. Justice Department, Healthpoint had submitted false statements about Xenaderm to get Medicaid and Medicare money. The active ingredient in Xenaderm was found ineffective by the FDA back in the 70s, and prosecutors alleged that Healthpoint had acted with full knowledge that the ingredient, trypsin, was not approved by FDA.

In December, 2012, Healthpoint agreed to a settlement of up to $33 million with 47 states and $15 million for payment to the Medicare prescription drug benefit program.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!

Healthpoint is by no means alone in such practices. A number of companies, starting with Eon Labs in 2010, have been cornered by the DOJ over false claims. Eon paid $3.5 million to resolve things. In October 2012, the FDA issued an order prohibiting more than four thousand online pharmacies from selling FDA unapproved drugs.

Xenoderm was marketed for the treatment of bed sores and other sores caused by pressure.



Litigation Attorney


Responsibilities The candidate should be able to independently manage own caseload through all ph...

Apply now

Sr. Trial Attorney


Bodily Injury Auto, Bodily Injury Commercial, Bodily Injury Homeowners, Commercial Auto, Commercial ...

Apply now

Landlord Tenant Counsel (Corporate)

USA-MD-College Park

WHAT WE ARE LOOKING FOR: This position advises executive, senior management and managers on various...

Apply now

Attorney with 1+ year experience - Position is in Probate Law


Looking for an associate attorney with at least one year of experience.  We are a boutique prob...

Apply now




Search Now

Business and Transactional Associate Attorney


Middletown office of a BCG Attorney Search Top Ranked Law Firm seeks business and transactional asso...

Apply Now

Business and Transactional Associate Attorney


Hartford office of a BCG Attorney Search Top Ranked Law Firm seeks business and transactional associ...

Apply Now

Business and Transactional Associate Attorney

USA-CT-East Haven

East Haven office of a BCG Attorney Search Top Ranked Law Firm seeks business and transactional asso...

Apply Now

Most Popular


To Top